Showing results (71-80 of 85) with videos related to
Sort By:
Pageof 9
Matrix Biology : Journal of the International Society for Matrix Biology|October 1, 1995
Extensive alternate exon usage at the 5' end of the sheep tropoelastin geneJ C Mauch, L B Sandberg, P J Roos, et al.Skin Pharmacology and Physiology|July 5, 2012
Dexpanthenol modulates gene expression in skin wound healing in vivoR Heise, C Skazik, Y Marquardt, et al.Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|January 27, 2021
[Brain metastases-Interdisciplinary approach towards a personalized treatment]S Grau, M Herling, C Mauch, et al.British Journal of Cancer|August 26, 2010
MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcomeJ C Hassel, A Sucker, L Edler, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|February 16, 2019
Extended surgical safety margins and ulceration are associated with an improved prognosis in pleomorphic dermal sarcomasO D Persa, C Loquai, M Wobser, et al.The Journal of Investigative Dermatology|January 1, 1992
Migration of a human keratinocyte cell line (HACAT) to interstitial collagen type I is mediated by the alpha 2 beta 1-integrin receptorK Scharffetter-Kochanek, C E Klein, G Heinen, et al.International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|May 26, 2021
Noninvasive thyroid histotripsy treatment: proof of concept study in a porcine modelJohn F Swietlik, Scott C Mauch, Emily A Knott, et al.Journal of Cancer Research and Clinical Oncology|March 6, 2007
Chemoimmunotherapy for cutaneous melanoma with dacarbazine and epifocal contact sensitizers: results of a nationwide survey of the German Dermatologic Co-operative Oncology GroupP Terheyden, A-K Kortüm, H-J Schulze, et al.Oncogene|August 20, 2013
The telomere profile distinguishes two classes of genetically distinct cutaneous squamous cell carcinomasC Leufke, J Leykauf, D Krunic, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 15, 2018
Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trialV Urbonas, D Schadendorf, L Zimmer, et al.Pageof 9